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BMI

:   body mass index

CI

:   confidence interval

HR

:   hazard ratio

MVPA

:   moderate‐to‐vigorous physical activity

PHC

:   public health center

1. INTRODUCTION {#cas14304-sec-0001}
===============

Sedentary behavior is any waking behavior characterized by an energy expenditure less than or equal to 1.5 metabolic equivalents, while in a sitting, reclining, or lying posture.[1](#cas14304-bib-0001){ref-type="ref"} Particularly, long sitting time at work is suggested to be an important risk factor for a number of adverse health outcomes, including diabetes mellitus,[2](#cas14304-bib-0002){ref-type="ref"} some cancers,[3](#cas14304-bib-0003){ref-type="ref"} and mortality,[2](#cas14304-bib-0002){ref-type="ref"}, [4](#cas14304-bib-0004){ref-type="ref"}, [5](#cas14304-bib-0005){ref-type="ref"} independent of MVPA. In a recent meta‐analysis of 21 cohort and 22 case‐control studies, the author reported an association between occupational sitting time and an increased risk of colon cancer.[3](#cas14304-bib-0003){ref-type="ref"} However, evidence on the association between occupational sitting time and cancer risk at other sites is not consistent. Additionally, despite differences in working time across countries,[6](#cas14304-bib-0006){ref-type="ref"} few studies[7](#cas14304-bib-0007){ref-type="ref"}, [8](#cas14304-bib-0008){ref-type="ref"} have reported the putative association between occupational sitting time and cancer incidence in an Asian population, including Japan. Given that sampling from a diverse group of 20 countries identified Japanese as having the longest total sitting time[9](#cas14304-bib-0009){ref-type="ref"} and that approximately 65% of total sitting time on workdays was spent sitting at work in both men and women,[10](#cas14304-bib-0010){ref-type="ref"} it is important to evaluate the association between occupational sitting time and risk of cancer incidence in Japanese populations. Furthermore, it is also unknown whether high levels of physical activity in leisure time eliminate any cancer risk by long sitting time at work.

Here, we examined the association between occupational sitting time and the risk of total and site‐specific cancer in a large Japanese population.

2. MATERIALS AND METHODS {#cas14304-sec-0002}
========================

2.1. Study cohort {#cas14304-sec-0003}
-----------------

The Japan Public Health Center‐based Prospective study consists of 2 cohorts, cohort I and cohort II, which started in 1990 and 1993, respectively. Cohort I included residents aged 40‐59 years in 5 Japanese PHC areas (Iwate, Akita, Nagano, Okinawa, and Tokyo), and cohort II included residents aged 40 to 69 years in 6 PHC areas (Ibaraki, Niigata, Kochi, Nagasaki, Okinawa, and Osaka). Details of the study design have been reported previously.[11](#cas14304-bib-0011){ref-type="ref"} This study consisted of baseline, as well as 5‐year (second) and 10‐year (third) follow‐up surveys. Study participants were informed of the aims of the study, and those who completed the survey questionnaire were regarded as consenting to participation. The study was approved by the Institutional Review Board of the National Cancer Center, Tokyo, Japan.

At baseline survey, 140 420 individuals were identified as constituting the study population. In the present analysis, we excluded Tokyo participants from the analyses because data on cancer incidence were not available. In this study, the 10‐year follow‐up survey undertaken in 2000‐2003 was defined as a starting point, because that survey included more comprehensive information on occupational sitting time than the baseline or 5‐year follow‐up survey. Participants aged 50‐79 years were followed until 2013. The questionnaire was used to collect information on the medical history and lifestyle variables of the participants. After excluding 27 612 participants who were ineligible (non‐Japanese nationality, incorrect late report of migration occurring before the starting point, or incorrect birth data) or had died, moved out of the study area, or were lost to follow‐up before the starting point, 112 808 participants were eligible for participation. Of these, a total of 93 813 participants responded to the 10‐year follow‐up questionnaire (response rate 83.2%).

2.2. Occupational sitting time and physical activity in leisure time {#cas14304-sec-0004}
--------------------------------------------------------------------

The main exposure variable, occupational sitting time, was assessed with the question "How long do you spend in the following tasks at work?", as in a previous study.[4](#cas14304-bib-0004){ref-type="ref"} Participants were asked to report the average duration for each of "sitting tasks", "standing tasks", "walking tasks", and "strenuous tasks" using the following options: (i) none; (ii) 0 to \<1; (iii) 1 to \<3; (iv) 3 to \<5; (v) 5 to \<7; (vi) 7 to \<9; (vii) 9 to \<11; and (viii) ≥11 hours/day. Occupational sitting time was then categorized into 5 groups: short, \<1 hours/day; 1 to \<3 hours/day; 3 to \<5 hours/day; 5 to \<7 hours/day; or longer, ≥7 hours/day.

We assessed MVPA time in leisure time as covariates and to undertake subgroup analyses. Participants were asked "How often do you engage in the following activities in your leisure time?" with the following possible answers: (i) walking slowly; (ii) brisk walking; (iii) moderate‐intensity activity, such as playing golf or gardening; and (iv) vigorous intensity activity, such as jogging or playing tennis. They were then asked the frequency options of: (i) \<1 time/month; (ii) 1‐3 times/month; (iii) 1‐2 times/week; (iv) 3‐4 times/week; and (v) almost every day; and the duration options (time/session) of: (i) \<30 minutes; (ii) 30 to \<59 minutes; (iii) 1 to \<2 hours; (iv) 2 to \<3 hours; (v) 3 to \<4 hours; and (vi) ≥4 hours. We defined "brisk walking", "moderate‐intensity activity", and "vigorous intensity activity" as MVPA in leisure time.[12](#cas14304-bib-0012){ref-type="ref"} The average time of MVPA (minutes/week) in leisure time was determined by multiplying frequency and duration.

2.3. Follow‐up and identification of cancer cases {#cas14304-sec-0005}
-------------------------------------------------

All participants in this study were followed from the starting point until 31 December 2013, except for one PHC area, where follow‐up was until the end of 2012. Cancer incidence was identified by active cancer patient notification through the major local hospitals in the study area and by data linkage with population‐based cancer registries. During the follow‐up period, 13 612 (14.5%) participants died, 3983 (4.2%) moved out of the study area, and 53 (0.1%) were lost to follow‐up. Cancer sites were coded according to the International Classification of Diseases for Oncology, Third Edition. The proportion of total cancer cases ascertained by death certificate only was 4.2%, which was considered satisfactory for the present study. If multiple cancers had been diagnosed at different times, the earliest cancer diagnosis date was used in this analysis.

2.4. Statistical analysis {#cas14304-sec-0006}
-------------------------

Of the 93 813 participants who responded to the 10‐year follow‐up questionnaire, 6734 aged 75 years and older, 2914 with a history of cancer, 4407 with a history of cardiovascular disease, 1481 with moderate or severe physical limitation, and 3331 with missing information for any variable used in the present analysis were excluded. Furthermore, with regard to occupation, 6711 men (18.8%) and 6497 women (15.3%) who were not presently employed, 43 men and 16 740 women who were working in home duties, 5130 who worked for at least 3 hours daily, and 6518 who had changed jobs within the last 5 years were also excluded. Finally, 33 307 participants (20 030 men and 13 277 women) were eligible for analysis. Person‐years of follow‐up were calculated for each subject from the starting point until the date of cancer diagnosis, date of migration from a study to a nonstudy area, date of death, or to the end of follow‐up, whichever occurred first.

Participant characteristics at the starting point were compared by analysis of variance or Kruskal‐Wallis tests. Hazard ratios and 95% CI between occupational sitting time and cancer risks were calculated using Cox proportional hazard regression models. All analyses were done using SAS version 9.3 (SAS Institute, Cary, NC, USA).

The basic models were adjusted for age (continuous) and area (10 PHCs). Multivariate models included related covariates such as history of diabetes (no, yes), smoking status (never, former, or current), alcohol intake status (nondrinker or occasional drinker, 1‐150 g/week or ≥150 g/week), BMI (\<18.5, 18.5‐24.9, 25‐29, or ≥30), coffee intake (almost none, 1‐4 times/week, 1‐2 cups/day, or ≥3 cups/day), walking task time at work (continuous), strenuous task time at work (continuous), MVPA time in leisure time (continuous), type of job (primary industry, or secondary or tertiary industry) and total working hours (continuous). We added a covariate for age at menopause (\<44, 45‐49, ≥50 years, or unknown) to examine associations between occupational sitting time and breast, ovary, and endometrial cancer. Subgroup analyses were undertaken by BMI (\<25 or ≥25) and MVPA time in leisure time (\<30 minutes/week or ≥30 minutes/week). To avoid potential bias arising from the fact that physical activity declines early in the course of cancer, analyses were repeated after excluding cancer cases diagnosed within the first 3 years of follow‐up. We also undertook sensitivity analyses that were limited to the full‐time workers (≥7 hours/day). We tested for linear trends by assignment of ordinal value categories of occupational sitting time. Furthermore, we calculated *P* interaction values by a likelihood‐ratio test to compare Cox proportional hazards models with and without cross‐product terms for occupational siting time (\<3 hours or ≥3 hours) and BMI (\<25 or ≥25) and MVPA time in leisure time (\<30 minutes/week or ≥30 minutes/week). All statistical tests reported were 2‐sided, and differences were considered significant at *P* \< .05.

3. RESULTS {#cas14304-sec-0007}
==========

During 373 809 person‐years of follow‐up (average follow‐up, 10.2 years) for 33 307 participants, a total of 3807 cancer cases were newly diagnosed and included in the analyses. Participant characteristics at starting points according to occupational sitting time are shown in Table [1](#cas14304-tbl-0001){ref-type="table"}. Participants with long occupational sitting time were younger, had greater BMI (men only), higher coffee intake, higher prevalence of diabetes (men only), shorter walking time at work, shorter strenuous time at work and undertook longer MVPA time in leisure time (men only).

###### 

Baseline characteristics of study participants according to daily occupational sitting time

                                                  Occupational sitting time (h)   *P* value                                                       
  ----------------------------------------------- ------------------------------- --------------- --------------- --------------- --------------- --------
  Men (n = 20 030)                                                                                                                                
  No. of subjects                                 5410                            5140            3267            2597            3616             
  Age (y), mean ± SD                              58.6 ± 6.4                      58.4 ± 6.4      58.0 ± 6.3      57.5 ± 5.9      56.8 ± 5.4      \<.001
  BMI, mean ± SD                                  23.6 ± 2.9                      23.8 ± 2.9      24.0 ± 2.9      24.1 ± 2.9      24.0 ± 2.9      \<.001
  Current smoker, %                               43.9                            44.0            43.7            42.8            43.7            .603
  Alcohol intake (≥150 ethanol g/wk), %           54.2                            54.4            52.2            51.9            52.9            .044
  Coffee intake (daily), %                        28.8                            33.7            40.6            43.0            40.9            \<.001
  Diabetes, %                                     6.4                             7.6             7.2             8.1             9.0             \<.001
  Walking time at work (h/d), mean ± SD           3.1 ± 2.9                       2.9 ± 2.5       2.1 ± 2.1       1.6 ± 1.8       2.0 ± 2.7       \<.001
  Strenuous time at work (h/d), mean ± SD         3.3 ± 2.9                       2.7 ± 2.5       1.7 ± 2.2       1.2 ± 1.9       1.6 ± 2.6       \<.001
  MVPA time in leisure time (min/wk), mean ± SD   111.1 ± 251.6                   135.4 ± 263.0   154.2 ± 265.9   155.1 ± 256.7   146.3 ± 269.0   \<.001
  Type of job                                                                                                                                      
  Primary industry, %                             28.0                            23.1            16.7            10.9            9.1             \<.001
  Secondary or tertiary industry, %               72.0                            76.9            83.3            89.0            90.9            
  Total working hours, mean ± SD                  7.8 ± 1.8                       8.0 ± 2.0       8.0 ± 2.1       8.3 ± 1.9       9.1 ± 1.7       \<.001
  Women (n = 13 277)                                                                                                                              
  No. of subjects                                 3305                            3800            2435            1634            2103             
  Age (y), mean ± SD                              58.4 ± 6.2                      58.3 ± 6.3      58.2 ± 6.2      57.3 ± 6.1      56.5 ± 5.4      .058
  BMI, mean ± SD                                  23.5 ± 3.2                      23.6 ± 3.1      23.7 ± 3.2      23.5 ± 3.3      23.6 ± 3.2      .105
  Current smoker, %                               5.4                             5.9             6.1             5.8             5.4             .966
  Alcohol intake (≥150 ethanol g/wk), %           5.1                             5.2             5.6             5.1             5.0             .981
  Coffee intake (daily), %                        42.5                            45.2            45.4            48.7            49.7            \<.001
  Diabetes, %                                     3.0                             3.5             3.4             3.1             3.1             .972
  Walking time at work (h/d), mean ± SD           3.7 ± 3.2                       3.4 ± 2.8       2.9 ± 2.5       2.2 ± 2.1       2.5 ± 2.8       \<.001
  Strenuous time at work (h/d), mean ± SD         2.3 ± 2.7                       1.9 ± 2.4       1.3 ± 2.0       1.0 ± 1.8       1.3 ± 2.4       \<.001
  MVPA time in leisure time (min/wk), mean ± SD   113.8 ± 248.9                   131.2 ± 258.7   141.6 ± 288.3   127.2 ± 233.4   116.3 ± 240.3   .048
  Age at menopause (≥50 y), %                     47.7                            48.6            47.2            46.9            47.0            \<.001
  Type of job                                                                                                                                     
  Primary industry, %                             29.2                            25.8            20.4            16.6            13.8            \<.001
  Secondary or tertiary industry, %               70.8                            74.2            79.6            83.4            86.2            
  Total working hours, mean ± SD                  7.9 ± 2.3                       7.9 ± 2.4       7.7 ± 2.4       8.1 ± 2.2       9.0 ± 1.9       \<.001

Abbreviations: BMI, body mass index; MVPA, moderate‐to‐vigorous physical activity.
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Table [2](#cas14304-tbl-0002){ref-type="table"} shows age‐ and area‐adjusted and multivariable HRs and 95% CIs for total and site‐specific cancer according to occupational sitting time in men. Occupational sitting time was marginally associated with the risk of total cancer, with multivariable HRs for the ≥7 h vs 1 to \<3 h category of 1.12 (95% CI = 0.99‐1.26, *P* for trend = 0.071). Furthermore, long sitting time at work was significantly associated with an increased risk of pancreas cancer, with multivariable HRs for the ≥7 h vs 1 to \<3 h category of 2.25 (95% CI = 1.17‐4.34, *P* for trend = 0.021) (Table [2](#cas14304-tbl-0002){ref-type="table"}).

###### 

Hazard ratios for cancer incidence at total and specific sites according to daily occupational sitting time in men

                              Occupational sitting time (h)   *P* for trend[a](#cas14304-note-0005){ref-type="fn"}                                                            
  --------------------------- ------------------------------- ------------------------------------------------------ ------------------ ------------------ ------------------ ------
  Men                                                                                                                                                                         
  Total                                                                                                                                                                       
  Number of subjects          5410                            5140                                                   3267               2597               3616                
  Person‐years                60 402                          56 687                                                 35 600             28 125             39 954              
  Number of cases             788                             728                                                    479                347                500                 
  Age‐ and area‐adjusted HR   1.02 (0.92‐1.13)                1.00 (ref)                                             1.08 (0.97‐1.22)   1.03 (0.91‐1.17)   1.13 (1.00‐1.26)   .080
  Multivariable HR            1.03 (0.93‐1.14)                1.00 (ref)                                             1.08 (0.96‐1.21)   1.03 (0.90‐1.17)   1.12 (0.99‐1.26)   .071
  Esophagus                                                                                                                                                                   
  Number of cases             30                              30                                                     12                 8                  20                  
  Age‐ and area‐adjusted HR   0.96 (0.58‐1.59)                1.00 (ref)                                             0.65 (0.33‐1.27)   0.55 (0.25‐1.20)   1.02 (0.58‐1.80)   .856
  Multivariable HR            0.92 (0.55‐1.53)                1.00 (ref)                                             0.72 (0.37‐1.42)   0.65 (0.29‐1.43)   1.05 (0.58‐1.87)   .924
  Stomach                                                                                                                                                                     
  Number of cases             155                             144                                                    94                 68                 91                  
  Age‐ and area‐adjusted HR   1.00 (0.80‐1.25)                1.00 (ref)                                             1.09 (0.84‐1.41)   1.02 (0.76‐1.36)   1.02 (0.78‐1.33)   .945
  Multivariable HR            0.99 (0.79‐1.25)                1.00 (ref)                                             1.09 (0.84‐1.41)   1.04 (0.78‐1.40)   1.08 (0.82‐1.41)   .568
  Colorectal                                                                                                                                                                  
  Number of cases             134                             135                                                    107                68                 111                 
  Age‐ and area‐adjusted HR   0.96 (0.75‐1.22)                1.00 (ref)                                             1.28 (0.99‐1.65)   1.06 (0.79‐1.41)   1.26 (0.98‐1.62)   .137
  Multivariable HR            0.99 (0.78‐1.25)                1.00 (ref)                                             1.26 (0.98‐1.64)   1.02 (0.76‐1.37)   1.17 (0.91‐1.52)   .319
  Colon                                                                                                                                                                       
  Number of cases             76                              87                                                     76                 50                 73                  
  Age‐ and area‐adjusted HR   0.85 (0.62‐1.16)                1.00 (ref)                                             1.41 (1.03‐1.92)   1.20 (0.85‐1.71)   1.29 (0.94‐1.77)   .149
  Multivariable HR            0.89 (0.65‐1.21)                1.00 (ref)                                             1.37 (1.00‐1.87)   1.13 (0.79‐1.61)   1.19 (0.87‐1.65)   .356
  Rectum                                                                                                                                                                      
  Number of cases             58                              48                                                     31                 18                 38                  
  Age‐ and area‐adjusted HR   1.15 (0.78‐1.68)                1.00 (ref)                                             1.04 (0.66‐1.64)   0.79 (0.46‐1.36)   1.21 (0.79‐1.85)   .597
  Multivariable HR            1.18 (0.80‐1.73)                1.00 (ref)                                             1.07 (0.68‐1.68)   0.80 (0.46‐1.39)   1.13 (0.73‐1.75)   .697
  Liver                                                                                                                                                                       
  Number of cases             29                              34                                                     25                 16                 30                  
  Age‐ and area‐adjusted HR   0.84 (0.51‐1.38)                1.00 (ref)                                             1.16 (0.69‐1.95)   0.97 (0.53‐1.76)   1.39 (0.85‐2.28)   .273
  Multivariable HR            0.84 (0.51‐1.39)                1.00 (ref)                                             1.18 (0.70‐1.98)   1.00 (0.54‐1.83)   1.54 (0.92‐2.58)   .159
  Pancreas                                                                                                                                                                    
  Number of cases             20                              16                                                     14                 13                 23                  
  Age‐ and area‐adjusted HR   1.18 (0.61‐2.29)                1.00 (ref)                                             1.48 (0.72‐3.03)   1.76 (0.85‐3.67)   2.33 (1.23‐4.44)   .008
  Multivariable HR            1.17 (0.61‐2.28)                1.00 (ref)                                             1.53 (0.74‐3.16)   1.82 (0.86‐3.84)   2.25 (1.17‐4.34)   .021
  Lung                                                                                                                                                                        
  Number of cases             109                             89                                                     69                 47                 55                  
  Age‐ and area‐adjusted HR   1.14 (0.86‐1.51)                1.00 (ref)                                             1.29 (0.94‐1.77)   1.17 (0.82‐1.66)   1.06 (0.76‐1.49)   .849
  Multivariable HR            1.12 (0.84‐1.48)                1.00 (ref)                                             1.30 (0.94‐1.79)   1.17 (0.82‐1.68)   1.07 (0.75‐1.51)   .685
  Kidney                                                                                                                                                                      
  Number of cases             20                              14                                                     10                 4                  9                   
  Age‐ and area‐adjusted HR   1.35 (0.68‐2.69)                1.00 (ref)                                             1.13 (0.50‐2.55)   0.60 (0.20‐1.82)   1.00 (0.43‐2.31)   .783
  Multivariable HR            1.35 (0.68‐2.69)                1.00 (ref)                                             1.11 (0.49‐2.51)   0.59 (0.19‐1.81)   1.04 (0.44‐2.47)   .731
  Bladder                                                                                                                                                                     
  Number of cases             28                              31                                                     12                 12                 10                  
  Age‐ and area‐adjusted HR   0.88 (0.52‐1.47)                1.00 (ref)                                             0.64 (0.33‐1.26)   0.86 (0.44‐1.67)   0.55 (0.27‐1.13)   .121
  Multivariable HR            0.86 (0.51‐1.44)                1.00 (ref)                                             0.68 (0.34‐1.33)   0.92 (0.46‐1.82)   0.56 (0.27‐1.17)   .188
  Prostate                                                                                                                                                                    
  Number of cases             158                             137                                                    78                 57                 91                  
  Age‐ and area‐adjusted HR   1.06 (0.84‐1.34)                1.00 (ref)                                             0.95 (0.72‐1.26)   0.93 (0.68‐1.26)   1.17 (0.90‐1.53)   .327
  Multivariable HR            1.09 (0.86‐1.37)                1.00 (ref)                                             0.92 (0.70‐1.22)   0.89 (0.65‐1.22)   1.10 (0.84‐1.45)   .543
  Other                                                                                                                                                                       
  Number of cases             108                             102                                                    68                 62                 65                  
  Age‐ and area‐adjusted HR   1.00 (0.76‐1.31)                1.00 (ref)                                             1.09 (0.80‐1.49)   1.31 (0.96‐1.80)   1.04 (0.76‐1.43)   .497
  Multivariable HR            1.02 (0.77‐1.33)                1.00 (ref)                                             1.07 (0.79‐1.47)   1.29 (0.93‐1.78)   1.01 (0.73‐1.39)   .550

Multivariable hazard ratio (HR) adjusted for age (continuous), area (10 public health center areas), history of diabetes (no, yes), smoking status (never, former, or current), alcohol intake status (nondrinker or occasional drinker, 1 to \<150 g/wk, or ≥150 g/wk), body mass index (\<18.5, 18.5‐24.9, 25‐29, or ≥30), coffee (almost none, 1‐4 times/wk, 1‐2 cups/d, or ≥3 cups/d), walking time at work (continuous), strenuous time at work (continuous), moderate‐to‐vigorous physical activity time in leisure time (continuous), type of job (primary industry, or secondary or tertiary industry) and total working hours (continuous).

Abbreviations: CI, confidence interval; ref, reference.

*P* for trend was tested by assignment of ordinal values into 4 groups (1 to \<3 h, 3 to \<5 h, 5 to \<7 h, and ≥7 h/d).
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In women, we observed no association between occupational sitting time and risk of total cancer, with multivariable HRs for the ≥7 h vs 1 to \<3 h category of 1.08 (95% CI = 0.87‐1.33, *P* for trend = 0.562) (Table [3](#cas14304-tbl-0003){ref-type="table"}). We found that long sitting time at work was significantly associated with an increased risk of lung cancer, with multivariable HRs for the ≥7 h vs 1 to \<3 h category of 2.80 (95% CI = 1.33‐5.90, *P* for trend = 0.013) (Table [3](#cas14304-tbl-0003){ref-type="table"}).

###### 

Hazard ratios for cancer incidence at total and specific sites according to daily occupational sitting time in women

                                                            Occupational sitting time (h)   *P* for trend[a](#cas14304-note-0008){ref-type="fn"}                                                              
  --------------------------------------------------------- ------------------------------- ------------------------------------------------------ ------------------- ------------------- ------------------ ------
  Women                                                                                                                                                                                                       
  Total                                                                                                                                                                                                       
  Number of subjects                                        3305                            3800                                                   2435                1634                2103                
  Person‐years                                              38 209                          43 884                                                 27 731              18 630              24 587              
  Number of cases                                           245                             247                                                    218                 113                 142                 
  Age‐ and area‐adjusted HR                                 1.15 (0.96‐1.37)                1.00 (ref)                                             1.40 (1.17‐1.68)    1.12 (0.89‐1.40)    1.10 (0.89‐1.35)   .403
  Multivariable HR                                          1.15 (0.97‐1.38)                1.00 (ref)                                             1.38 (1.15‐1.66)    1.09 (0.87‐1.36)    1.08 (0.87‐1.33)   .562
  Esophagus                                                                                                                                                                                                   
  Number of cases                                           3                               2                                                      3                   0                   0                   
  Age‐ and area‐adjusted HR                                 1.89 (0.31‐11.40)               1.00 (ref)                                             2.29 (0.38‐13.79)   ---                 ---                ---
  Multivariable HR                                          1.64 (0.25‐10.75)               1.00 (ref)                                             2.38 (0.35‐16.45)   ---                 ---                ---
  Stomach                                                                                                                                                                                                     
  Number of cases                                           28                              36                                                     23                  20                  20                  
  Age‐ and area‐adjusted HR                                 0.90 (0.55‐1.48)                1.00 (ref)                                             1.00 (0.59‐1.68)    1.32 (0.76‐2.29)    1.06 (0.61‐1.83)   .569
  Multivariable HR                                          0.89 (0.54‐1.46)                1.00 (ref)                                             1.03 (0.61‐1.74)    1.35 (0.78‐2.36)    1.03 (0.59‐1.81)   .696
  Colorectal                                                                                                                                                                                                  
  Number of cases                                           55                              54                                                     46                  32                  25                  
  Age‐ and area‐adjusted HR                                 1.18 (0.81‐1.72)                1.00 (ref)                                             1.35 (0.91‐2.00)    1.47 (0.95‐2.29)    0.94 (0.58‐1.51)   .743
  Multivariable HR                                          1.22 (0.84‐1.78)                1.00 (ref)                                             1.26 (0.85‐1.87)    1.36 (0.87‐2.11)    0.94 (0.58‐1.53)   .849
  Colon                                                                                                                                                                                                       
  Number of cases                                           40                              41                                                     36                  23                  19                  
  Age‐ and area‐adjusted HR                                 1.15 (0.74‐1.78)                1.00 (ref)                                             1.38 (0.88‐2.16)    1.38 (0.83‐2.31)    0.94 (0.54‐1.62)   .886
  Multivariable HR                                          1.20 (0.77‐1.85)                1.00 (ref)                                             1.27 (0.81‐2.00)    1.24 (0.74‐2.09)    0.91 (0.52‐1.60)   .967
  Rectum                                                                                                                                                                                                      
  Number of cases                                           15                              13                                                     10                  9                   6                   
  Age‐ and area‐adjusted HR                                 1.28 (0.61‐2.70)                1.00 (ref)                                             1.26 (0.55‐2.87)    1.77 (0.75‐4.15)    0.95 (0.36‐2.50)   .681
  Multivariable HR                                          1.27 (0.60‐2.68)                1.00 (ref)                                             1.20 (0.52‐2.76)    1.76 (0.74‐4.16)    1.00 (0.37‐2.69)   .821
  Liver                                                                                                                                                                                                       
  Number of cases                                           6                               10                                                     3                   1                   1                   
  Age‐ and area‐adjusted HR                                 0.69 (0.25‐1.90)                1.00 (ref)                                             0.50 (0.14‐1.81)    0.27 (0.03‐2.14)    0.23 (0.03‐1.79)   .076
  Multivariable HR                                          0.66 (0.24‐1.84)                1.00 (ref)                                             0.58 (0.16‐2.13)    0.31 (0.04‐2.49)    0.30 (0.04‐2.20)   .109
  Pancreas                                                                                                                                                                                                    
  Number of cases                                           10                              8                                                      10                  7                   4                   
  Age‐ and area‐adjusted HR                                 1.43 (0.56‐3.63)                1.00 (ref)                                             2.05 (0.81‐5.21)    2.27 (0.82‐6.27)    1.01 (0.30‐3.39)   .582
  Multivariable HR                                          1.36 (0.53‐3.46)                1.00 (ref)                                             2.10 (0.82‐5.37)    2.12 (0.75‐5.96)    0.90 (0.26‐3.07)   .858
  Lung                                                                                                                                                                                                        
  Number of cases                                           25                              13                                                     20                  6                   17                  
  Age‐ and area‐adjusted HR                                 2.23 (1.14‐4.37)                1.00 (ref)                                             2.50 (1.24‐5.02)    1.19 (0.45‐3.14)    2.72 (1.31‐5.64)   .028
  Multivariable HR                                          2.17 (1.11‐4.26)                1.00 (ref)                                             2.63 (1.30‐5.30)    1.26 (0.48‐3.35)    2.80 (1.33‐5.90)   .013
  Kidney                                                                                                                                                                                                      
  Number of cases                                           3                               2                                                      4                   3                   0                   
  Age‐ and area‐adjusted HR                                 1.82 (0.30‐10.94)               1.00 (ref)                                             3.25 (0.59‐17.83)   4.46 (0.73‐27.07)   ---                ---
  Multivariable HR                                          1.73 (0.29‐10.44)               1.00 (ref)                                             3.40 (0.61‐18.91)   4.15 (0.66‐26.11)   ---                ---
  Bladder                                                                                                                                                                                                     
  Number of cases                                           3                               5                                                      2                   3                   2                   
  Age‐ and area‐adjusted HR                                 0.79 (0.19‐3.33)                1.00 (ref)                                             0.61 (0.12‐3.15)    1.60 (0.38‐6.80)    0.86 (0.16‐4.53)   .927
  Multivariable HR                                          0.83 (0.20‐3.50)                1.00 (ref)                                             0.54 (0.10‐2.81)    1.42 (0.33‐6.13)    0.79 (0.14‐4.27)   .927
  Breast                                                                                                                                                                                                      
  Number of cases                                           44                              43                                                     38                  20                  29                  
  Age‐ and area‐adjusted HR                                 1.18 (0.77‐1.80)                1.00 (ref)                                             1.40 (0.91‐2.17)    1.08 (0.63‐1.83)    1.18 (0.73‐1.89)   .572
  Multivariable HR[b](#cas14304-note-0009){ref-type="fn"}   1.21 (0.79‐1.84)                1.00 (ref)                                             1.39 (0.89‐2.15)    1.04 (0.61‐1.78)    1.11 (0.69‐1.81)   .618
  Ovarian                                                                                                                                                                                                     
  Number of cases                                           7                               7                                                      4                   0                   6                   
  Age‐ and area‐adjusted HR                                 1.13 (0.40‐3.24)                1.00 (ref)                                             0.86 (0.25‐2.95)    ---                 1.45 (0.48‐4.35)   ---
  Multivariable HR[b](#cas14304-note-0009){ref-type="fn"}   1.11 (0.38‐3.11)                1.00 (ref)                                             0.93 (0.27‐3.22)    ---                 1.51 (0.48‐4.72)   ---
  Endometrial                                                                                                                                                                                                 
  Number of cases                                           17                              13                                                     8                   8                   4                   
  Age‐ and area‐adjusted HR                                 1.45 (0.70‐2.99)                1.00 (ref)                                             1.01 (0.42‐2.43)    1.49 (0.62‐3.60)    0.51 (0.17‐1.59)   .463
  Multivariable HR[b](#cas14304-note-0009){ref-type="fn"}   1.37 (0.66‐2.83)                1.00 (ref)                                             0.99 (0.41‐2.40)    1.41 (0.58‐3.47)    0.49 (0.15‐1.52)   .314
  Other                                                                                                                                                                                                       
  Number of cases                                           48                              58                                                     58                  17                  36                  
  Age‐ and area‐adjusted HR                                 0.96 (0.66‐1.41)                1.00 (ref)                                             1.58 (1.10‐2.27)    0.71 (0.41‐1.22)    1.21 (0.80‐1.84)   .903
  Multivariable HR                                          0.97 (0.66‐1.42)                1.00 (ref)                                             1.53 (1.06‐2.21)    0.68 (0.39‐1.18)    1.16 (0.75‐1.78)   .885

Multivariable hazard ratio (HR) adjusted for age (continuous), area (10 public health center areas), history of diabetes (no, yes), smoking status (never, former or current), alcohol intake status (nondrinkers or occasional drinkers, 1 to \<150 g/wk, or ≥150 g/wk), body mass index (\<18.5, 18.5‐24.9, 25‐29, or ≥30), coffee (almost none, 1‐4 times/wk, 1‐2 cups/d, or ≥3 cups/d), walking time at work (continuous), strenuous time at work (continuous), moderate‐to‐vigorous physical activity time in leisure time (continuous), type of job (primary industry, or secondary or tertiary industry), and total working hours (continuous).

Abbreviations: ---, not applicable; CI, confidence interval; ref, reference.

*P* for trend was tested by assignment of ordinal values into 4 groups (1 to \<3 h, 3 to \<5 h, 5 to \<7 h, and ≥7 h/d).

Additional adjusted for age at menopause (\<44, 45‐49, ≥50 y, or unknown).

John Wiley & Sons, Ltd

No association between extremely short occupational sitting time and total or any site‐specific cancer was observed in men (Table [2](#cas14304-tbl-0002){ref-type="table"}) or women (Table [3](#cas14304-tbl-0003){ref-type="table"}), except for lung cancer in women.

Table [4](#cas14304-tbl-0004){ref-type="table"} shows multivariable HRs and 95% CIs for total and pancreas cancer by BMI and MVPA time in leisure time in men. Regarding BMI, we observed a positive association between occupational sitting time and risk of pancreas cancer in men who had low BMI, with multivariable HRs for the \<3 h vs ≥3 h category of 1.83 (95% CI = 1.07‐3.13). In contrast, no association was shown between occupational sitting time and pancreas cancer risk in men who had high BMI. However, we did not detect statistically significant interactions between occupational sitting time and BMI for pancreas cancer. Additionally, regarding MVPA time in leisure time, we did not observe statistically significantly associations between occupational sitting time and any cancer risk in men who had a short or long MVPA time in leisure time.

###### 

Hazard ratios for total and pancreas cancer incidence by body mass index and moderate‐to‐vigorous physical activity in leisure time in men

                                                              Occupational sitting time (h)   *P* for interaction   
  ----------------------------------------------------------- ------------------------------- --------------------- ------
  Total                                                                                                             
  BMI at baseline \<25                                                                                              
  Number of cases                                             1091                            890                    
  Multivariable HR[a](#cas14304-note-0011){ref-type="fn"}     1.00                            1.08 (0.99‐1.19)      .831
  BMI at baseline ≥25                                                                                               
  Number of cases                                             425                             436                    
  Multivariable HR[a](#cas14304-note-0011){ref-type="fn"}     1.00                            1.03 (0.89‐1.18)       
  Short MVPA time (\<30 min/wk) in leisure time at baseline                                                         
  Number of cases                                             851                             618                    
  Multivariable HR[b](#cas14304-note-0012){ref-type="fn"}     1.00                            1.08 (0.97‐1.21)      .315
  Long MVPA time (≥30 min/wk) in leisure time at baseline                                                           
  Number of cases                                             665                             708                    
  Multivariable HR[b](#cas14304-note-0012){ref-type="fn"}     1.00                            1.05 (0.94‐1.18)       
  Pancreas                                                                                                          
  BMI at baseline \< 25                                                                                             
  Number of cases                                             26                              36                     
  Multivariable HR[a](#cas14304-note-0011){ref-type="fn"}     1.00                            1.83 (1.07‐3.13)      .684
  BMI at baseline ≥ 25                                                                                              
  Number of cases                                             10                              14                     
  Multivariable HR[a](#cas14304-note-0011){ref-type="fn"}     1.00                            1.53 (0.65‐3.61)       
  Short MVPA time (\<30 min/wk) in leisure time at baseline                                                         
  Number of cases                                             22                              27                     
  Multivariable HR[b](#cas14304-note-0012){ref-type="fn"}     1.00                            1.74 (0.96‐3.15)      .965
  Long MVPA time (≥30 min/wk) in leisure time at baseline                                                           
  Number of cases                                             14                              23                     
  Multivariable HR[b](#cas14304-note-0012){ref-type="fn"}     1.00                            1.80 (0.89‐3.66)       

Abbreviations: CI, confidence interval; HR, hazard ratio; MVPA, moderate‐to‐vigorous physical activity.

Adjusted for age (continuous), area (10 public health center areas), history of diabetes (no, yes), smoking status (never, former or current), alcohol intake status (non ‐ or occasional drinkers, 1 to \<150 g/wk, or ≥150 g/wk), coffee (almost none, 1‐4 times/wk, 1‐2 cups/d, or ≥3 cups/d), walking time at work (continuous), strenuous time at work (continuous), moderate‐to‐vigorous physical activity time in leisure time (continuous), type of job (primary industry, or secondary or tertiary industry), and total working hours (continuous).

Adjusted for age (continuous), area (10 public health center areas), history of diabetes (no, yes), smoking status (never, former or current), alcohol intake status (nondrinkers or occasional drinkers, 1 to \<150 g/wk, or ≥150 g/wk), body mass index (BMI; \<18.5, 18.5‐24.9, 25‐29, or ≥30), coffee (almost none, 1‐4 times/wk, 1‐2 cups/d, or ≥3 cups/d), walking time at work (continuous), strenuous time at work (continuous), type of job (primary industry, or secondary or tertiary industry), and total working hours (continuous).

John Wiley & Sons, Ltd

There were no substantial differences in results on the inclusion of participants who worked in home duties in women (Table [S1](#cas14304-sup-0001){ref-type="supplementary-material"}) with and without adjustment for BMI (data not shown). Sensitivity analyses after excluding participants with a cancer diagnosis within the first 3‐year follow‐up period or without full‐time work showed no substantial differences in findings (data not shown).

4. DISCUSSION {#cas14304-sec-0008}
=============

In this study, we found that long time spent sitting at work showed statistically significant associations with an increased risk of pancreas cancer in men and lung cancer in women. Furthermore, we also found a marginally positive association between long occupational sitting time and total cancer risk in men. These findings are consistent with a guideline on physical activity that states that people should minimize the amount of time spent sitting.[13](#cas14304-bib-0013){ref-type="ref"}, [14](#cas14304-bib-0014){ref-type="ref"} It is becoming more important to reduce sitting time at work, because approximately 65% of total sitting time on workdays is spent sitting at work in both men and women[10](#cas14304-bib-0010){ref-type="ref"} and because desk workers and other sedentary occupations have increased in recent years.[15](#cas14304-bib-0015){ref-type="ref"} The findings of this study provided evidence that reducing occupational sitting time is also important from the perspective of cancer prevention.

Regarding pancreas cancer, 1 cohort study showed an association between sedentary work and increased risk of pancreas cancer in Finnish women,[16](#cas14304-bib-0016){ref-type="ref"} but not in men. To our knowledge, this is the first large cohort study to report a positive association between occupational sitting time and pancreas cancer risk in men. Our results in men support the previous finding in women,[16](#cas14304-bib-0016){ref-type="ref"} albeit that the interpretation of our result requires caution due to the small number of cases.

Several biological mechanisms to explain the observed positive association between sedentary behavior and cancer have been proposed, including adiposity, metabolic dysfunction, and chronic inflammation.[17](#cas14304-bib-0017){ref-type="ref"}, [18](#cas14304-bib-0018){ref-type="ref"} Previous experimental studies have also indicated that longer sedentary time promotes higher levels of insulin and leads to the development of insulin resistance,[19](#cas14304-bib-0019){ref-type="ref"}, [20](#cas14304-bib-0020){ref-type="ref"} because skeletal muscle plays an important role in uptake of glucose in blood, and even light‐intensity physical activity with relatively low muscle activation could contribute to glucose uptake.[21](#cas14304-bib-0021){ref-type="ref"}, [22](#cas14304-bib-0022){ref-type="ref"} In particular, although the mechanisms of the adverse influence of prolonged sitting time have not been precisely clarified, low activation of the large skeletal muscles involved in postural control could cause metabolic failure of lipid and glucose.[23](#cas14304-bib-0023){ref-type="ref"} Given that pancreas cancer is regarded as related to insulin,[24](#cas14304-bib-0024){ref-type="ref"}, [25](#cas14304-bib-0025){ref-type="ref"} an increased risk of pancreas cancer with a long time spent sitting at work might be plausible.

Three metaanalyses, by Schmid et al,[3](#cas14304-bib-0003){ref-type="ref"} Cong et al,[26](#cas14304-bib-0026){ref-type="ref"} and Ma et al,[27](#cas14304-bib-0027){ref-type="ref"} have all reported a positive association between occupational sitting time and colon cancer risk, with summary relative risks of 1.24 (95% CI = 1.09‐1.41), 1.30 (95% CI = 1.20‐1.40), and 1.24 (95% CI = 1.19‐1.29), respectively. However, 1 cohort study[28](#cas14304-bib-0028){ref-type="ref"} and 1 case‐control study[29](#cas14304-bib-0029){ref-type="ref"} in an Asian population included in these metaanalyses did not show a positive association. The lack of association in these previous studies[28](#cas14304-bib-0028){ref-type="ref"}, [29](#cas14304-bib-0029){ref-type="ref"} was reached by estimating the sitting time of participants based on job title. In the present study in Japanese men, our main results from self‐reported occupational sitting time with relatively large sample sizes also showed no statistically significant association between occupational sitting time and colon cancer risk. However, we did observe a marginally positive linear trend (*P* for trend = 0.060) between occupational sitting time and colon cancer risk in men when we undertook the same analysis using \<1 h as reference (data not shown). Given that many studies in Europe and North America[3](#cas14304-bib-0003){ref-type="ref"}, [26](#cas14304-bib-0026){ref-type="ref"}, [27](#cas14304-bib-0027){ref-type="ref"} have reported a positive association between occupational sitting time and colon cancer risk, and that obesity due to long sitting time could mediate increased risks for certain cancers, such as colorectal cancer, through shared mechanisms,[3](#cas14304-bib-0003){ref-type="ref"} our results could suggest a slightly increased risk of colon cancer in men, as in previous studies.[3](#cas14304-bib-0003){ref-type="ref"}, [26](#cas14304-bib-0026){ref-type="ref"}, [27](#cas14304-bib-0027){ref-type="ref"}

In women, occupational sitting time was significantly associated with lung cancer incidence in our study. To our knowledge, this is the first prospective cohort study to find a positive association between occupational sitting time and lung cancer risk. Our results are consistent with a cohort study that found that total sitting time, not occupational, was associated with increased risk of lung cancer in never‐smokers[30](#cas14304-bib-0030){ref-type="ref"} and a case‐control study that reported an association between long sitting and an increased risk of lung cancer in Europe female workers.[31](#cas14304-bib-0031){ref-type="ref"} In addition to the mechanism commonly proposed as a rationale for the association between sedentary behavior and cancer risk,[17](#cas14304-bib-0017){ref-type="ref"}, [18](#cas14304-bib-0018){ref-type="ref"} the positive association between occupational sitting time and lung cancer in women might imply the influence of other exposures, such as passive smoking, that have been reported to increase the risk of lung cancer at the workplace.[32](#cas14304-bib-0032){ref-type="ref"} Weiderpass and colleagues have reported a significant association between sedentary work and increased risk of colon cancer in Finnish women,[16](#cas14304-bib-0016){ref-type="ref"} whereas 2 cohort studies identified null associations between occupational sitting time and colon[28](#cas14304-bib-0028){ref-type="ref"} and colorectal[33](#cas14304-bib-0033){ref-type="ref"} cancer risk in women. With regard to breast cancer, the World Cancer Research Fund reports state that physical activity probably decreases risk of breast cancer (postmenopausal),[34](#cas14304-bib-0034){ref-type="ref"}, [35](#cas14304-bib-0035){ref-type="ref"} even though no significant association between occupational sitting time and breast cancer risk was reported in 2 cohort[8](#cas14304-bib-0008){ref-type="ref"}, [36](#cas14304-bib-0036){ref-type="ref"} or 4 case‐control studies.[32](#cas14304-bib-0032){ref-type="ref"}, [37](#cas14304-bib-0037){ref-type="ref"}, [38](#cas14304-bib-0038){ref-type="ref"}, [39](#cas14304-bib-0039){ref-type="ref"} The reason for the discrepancy in previous results by difference in exposure to physical activity and occupational sitting time is assumed to be that sedentary leisure‐time activities, such as sitting time to watch television, tend to be associated with adverse health outcomes because of the unhealthy behaviors that accompany them.[40](#cas14304-bib-0040){ref-type="ref"} Given that our study had a high proportion of women who were unemployed or working in home duties that we excluded for analysis, further research is required regarding the association between recreational sitting time and cancer, although our results support previous findings of a null association between occupational sitting time and cancer incidence in women.

We also found a statistically significant association between occupational sitting time and pancreas cancer risk in men with a low BMI, but not in men with a high BMI, although the interaction between occupational sitting time and BMI was not statistically significant. Body fatness is a risk factor for pancreas cancer incidence.[34](#cas14304-bib-0034){ref-type="ref"}, [35](#cas14304-bib-0035){ref-type="ref"} A decrease in time spent sitting at work might be more preventive against pancreas cancer in men with a low BMI, who are less affected by body fatness, than in men who are overweight or obese.

We found an increased risk of pancreas cancer with 3 h or more occupational sitting time in men with both short and long MVPA time at leisure time, although this was not statistically significant. These results might suggest that reducing occupational sitting time could lead to a decreased risk of pancreas cancer in men, regardless of leisure‐time physical activity.

Although we speculated that participants with an extremely short occupational sitting time would experience adverse effects because they spent a longer time standing at work than those with a long occupational sitting time (occupational sitting time \<1 h vs \>7 h; mean standing time 5.6 hours vs 3.0 hours), there were no associations between extremely short occupational sitting time and cancer incidence in this study except for lung cancer in women. Smith et al reported that occupations that predominantly involve standing were associated with an increased risk of heart disease.[41](#cas14304-bib-0041){ref-type="ref"} The reason for the increased risk of lung cancer in women in this study is not clear because the mechanisms of the adverse effect of incident heart disease with prolonged standing time at work, such as blood pooling in the lower limbs and increased hydrostatic venous pressure, and those of cancer development are different.

Strengths of this study include its prospective design, large sample size, high survey response rate (83.2%), and low rate of loss of follow‐up (0.1%). Because information on occupational sitting time was obtained before a subsequent cancer diagnosis, recall bias was unlikely to have influenced the results. Furthermore, the cancer registry in this study possesses sufficient quality to reduce the likelihood of misclassification of outcomes.

Several limitations of our study also warrant mention. First, because occupational sitting time was determined using a self‐reported questionnaire and included sitting time for commuting, we cannot rule out the possibility that our results were affected by misclassification of exposure. Nevertheless, we feel this approach is comparable to or an improvement over several previous cohort studies, which also estimated occupational sitting time by questionnaire, or by estimating from the individual participant's job title. Moreover, any misclassification of exposure would likely influence the results towards null. Second, we could not evaluate the content of the sitting time, such as with regard to interruptions in sitting time. Third, despite the large sample size and long follow‐up period, incidence of some cancers was small in women who had an occupational sitting time of over 5 hours. Thus, it was not possible to evaluate the association between occupational sitting time and some cancer risks. Fourth, we obtained information on education from participants in Cohort I only. We therefore adjusted for education level using Cohort I subjects only, but found no substantial difference in the results. Finally, other unknown risk factors might have confounded the association between occupational sitting time and cancer. Although we adjusted for and stratified by potential confounding variables, we could not fully exclude the effects of unmeasured confounders.

In conclusion, our study found a positive association between long occupational sitting time and increased risk of pancreas cancer in men and lung cancer in women. Given that adults spend most of their working hours sitting, our findings suggest that reducing long times spent sitting at work could be important for cancer prevention.
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